Robert F. Vizza Clinical Accelerator Initiative

The Clinical Accelerator Initiative (CAI) will advance the mission of the Lustgarten Foundation by accelerating the translation of research discoveries into clinical trials through the support of science-based clinical trials that will advance the development of new therapies for pancreatic cancer and our understanding of the underlying biology.

Applications to the CAI are by invitation and accepted on a rolling deadline. Investigators with potential trial concepts or interest in the program should contact Andrew Rakeman, VP of Research ([email protected]).


Lustgarten Equity, Accessibility, and Diversity (LEAD) Project

Pancreatic cancer does not impact all populations equally with significant differences in incidence and disparities in outcome across racial, ethnic, and socioeconomic groups in the United States. Despite this, pancreatic cancer patients from minority groups are significantly underrepresented in all phases of clinical trials.

The LEAD Project aims to increase recruitment and retention of underrepresented groups in pancreatic cancer clinical trials by supporting institutions that make intentional efforts to address barriers to participation among underrepresented groups and develop and implement specific tools to increase clinical trial participation.

Applications are due December 1, 2022 and must be submitted through ProposalCentral. A full description of the program is available.

For more information contact Sejin Chung, Program Scientist ([email protected])


Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg and John Robert Lewis

The Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg and John Robert Lewis, have been established to honor the life and legacies of Justice Ginsburg and Representative Lewis, who worked tirelessly to advance gender equality and civil rights, even while battling pancreatic cancer. The intent of this program is to support the development and diversity of talent working in pancreatic cancer research.

Letters of Intent are due October 18, 2022. A full description of the programs are available at www.aacr.org/grants/.


Lustgarten Foundation-Swim Across America-AACR Pancreatic Cancer Early Detection Research Grant

The Lustgarten Foundation-Swim Across America-AACR Pancreatic Cancer Early Detection Research Grant represents a joint effort to support innovative research to advance efforts towards the early detection and interception of pancreatic cancer. The proposed project may be basic, translational, clinical, or epidemiological in nature, must have direct applicability and relevance to the understanding, detection, diagnosis, or treatment of pancreatic cancer.

Letters of Intent are due October 18, 2022. A full description of the program is available at www.aacr.org/grants/.


Lustgarten Research Program Contacts:

Andrew Rakeman, Ph.D.
VP, Research
[email protected]

Sejin Chung, Ph.D.
Program Scientist
[email protected]

Sasha Singh
Grants Manager
[email protected]

Thanks for signing up!
Tell us a little more about yourself: